Verification evidence is still being completed.
PDF / print export
Aiforia Technologies
Helsinki, Finland
- Verified lead
- Jukka Tapaninen
- Lead status
- STATUS: VERIFIED MARCH 2026
- Leadership verification
- CEO
- 2026 technical specialization
- AI Pathology, Digital Histopathology, Clinical Decision Support, and Diagnostic Image Analysis
- Review cycle
- May 2026
- Full address
- Ratamestarinkatu 13 A, FI-00520 Helsinki, Finland
- Site coordinates
- Verification evidence is still being completed.
- Editorial review
- Memel Biotech editorial review
- Official leadership source
- Official AGM notice confirming the Helsinki operating address for Aiforia Technologies Plc.
- Editorial note
- Aiforia is published because official investor materials confirm current leadership and Helsinki address, while the official site clearly presents a pathology and clinical-diagnostics operating platform.
AI Pathology, Digital Histopathology, Clinical Decision Support, and Diagnostic Image Analysis
Public-company investor disclosure, Official Helsinki address disclosure, Clinical diagnostics and pathology platform claim
Aiforia is published because official investor materials confirm current leadership and Helsinki address, while the official site clearly presents a pathology and clinical-diagnostics operating platform.
Review coverage
Leadership
Facility
Certifications
Capabilities
Partners
Sources
Quality
Editorial verificationMemel Biotech directory review sign-off
Report generated02 Jun 2026, 01:40
Company profile · Helsinki, Finland
Aiforia Technologies
AI Pathology, Digital Histopathology, Clinical Decision Support, and Diagnostic Image Analysis · Commercial diagnostics-software platform
Aiforia Technologies runs ai pathology workflow development, clinical image analysis, and diagnostic decision support in Helsinki, Finland.
- Lead
- Jukka Tapaninen (verified ↗)
- Address
- Ratamestarinkatu 13 A, FI-00520 Helsinki, Finland (source ↗)
- Compliance
- Not yet on record
- Last reviewed
- 21 Mar 2026 (2mo ago)
- Scale
- Commercial diagnostics-software platform
- Capabilities
- AI Pathology Workflow Development · Clinical Image Analysis · Diagnostic Decision Support
- Founded
- 2013
- Headcount
- 51-200
- Company page (open ↗)
Clinical profileSTATUS: VERIFIED MARCH 2026
Jukka Tapaninen
CEO
Full addressRatamestarinkatu 13 A, FI-00520 Helsinki, Finland
Site coordinatesVerification evidence is still being completed.
Review cycleMay 2026
Physical site source
Official Aiforia AGM notice listing the Ratamestarinkatu 13 A Helsinki address.
Open sourceCommercial diagnostics-software platform
Helsinki, Finland. AI Pathology, Digital Histopathology, Clinical Decision Support, and Diagnostic Image Analysis. Review completed on 21 Mar 2026.
Finnish corporate governance and clinical-diagnostics software oversight
Public-company investor disclosure, Official Helsinki address disclosure, Clinical diagnostics and pathology platform claim
AI Pathology, Digital Histopathology, Clinical Decision Support, and Diagnostic Image Analysis
Aiforia is published because official investor materials confirm current leadership and Helsinki address, while the official site clearly presents a pathology and clinical-diagnostics operating platform.
Editorial note
Aiforia is published because official investor materials confirm current leadership and Helsinki address, while the official site clearly presents a pathology and clinical-diagnostics operating platform.
FULL TRUST REVIEW COMPLETE
Shown only when all seven trust checks are fully mapped in the directory.
Current review cycleMarch 2026
Capabilities
Core capabilities
Primary declared technical activities and areas of operating focus.
AI Pathology Workflow Development
Clinical Image Analysis
Diagnostic Decision Support
Verification source dossier
Verification source dossier
Official source set used to support leadership, physical-site, certification, and watch-note evidence.
Infrastructure
Declared infrastructure
Digital pathology analysis platform
AI model deployment workflow
Clinical image data infrastructure
Regulatory posture
Quality system coverage
GMP / GLP / ISO-13485 / FDA-Inspected are global quality-system standards. "Verified active" means the directory confirmed the certification is current; "Review in progress" means the cert status is currently being re-verified.
- GMP
- REVIEW IN PROGRESS 2026
- GLP
- REVIEW IN PROGRESS 2026
- ISO-13485
- REVIEW IN PROGRESS 2026
- FDA-Inspected
- REVIEW IN PROGRESS 2026
Verification history
Verification history
21 Mar 2026: Executive identity confirmed via official management disclosure.
21 Mar 2026: Full trust review completed.
FAQ
Frequently asked questions
- Where is Aiforia Technologies located?
- Aiforia Technologies operates from Ratamestarinkatu 13 A, FI-00520 Helsinki, Finland, Helsinki, Finland.
- Who runs Aiforia Technologies?
- Aiforia Technologies is led by Jukka Tapaninen, CEO. Verified 21 Mar 2026.
- What does Aiforia Technologies do?
- Aiforia Technologies runs ai pathology workflow development, clinical image analysis, and diagnostic decision support in Helsinki, Finland. Core capabilities: AI Pathology Workflow Development, Clinical Image Analysis, Diagnostic Decision Support.
Editorial context
Related technical briefs
Briefs that name Helsinki as a covered market or city.